Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann

Blood Adv (2022) 6 (2): 515–520.

https://doi.org/10.1182/bloodadvances.2021005532

Published: 2022

Includes: Supplemental data